Home › High Blood Pressure › NCT05479461
Technology-enabled Management Versus Usual Care for Blood Pressure
Recruiting
A Two-arm Parallel Randomized Clinical Trial of Implementation of Technology-enabled Management Versus Usual Care for Blood Pressure
Who can join
Ages 30 to 90 · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 30-90 yrs. * Smartphone ownership * Office SBP: ≥ 140 mm Hg * ≤ 2 current anti-HTN meds * Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose) * English or Spanish-speakers Exclusion Criteria: * Heart failure with reduced ejection fraction (EF \< 40%) * ESRD (GFR \<15) * Renal replacement therapy * Pregnant * Myocardial infarction or stroke within preceding 6 months * Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months * Prior solid organ transplantation * At the clinical discretion of the investigators * Enrolled in another clinical study
About the study
Two arm parallel randomized clinical trial
What is being tested
- Digital Hypertension Management System (other)
- Usual Care (other)
Sponsor: Stanford University · Participants: 200 · Started: Jun 13, 2023
Contact the study team
- Paul J Wang, MD · Phone: (650) 723-9363
- Meg Babakhanian, PhD · Phone: 818-618-4764
Official record on ClinicalTrials.gov — NCT05479461
Locations in the U.S.
| California | Stanford Health Care, Palo Alto |
| Georgia | Morehouse School of Medicine, Atlanta Lake Country Medical Group, Eatonton |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.